Université François Rabelais, INRA, UMR 0483 Université-INRA d'Immunologie Parasitaire, Vaccinologie et Biothérapie Anti-infectieuse, IFR136 Agents Transmissibles et Infectiologie, UFR de Pharmacie, 31 avenue Monge, 37200 Tours, France.
Vet Res. 2010 Jul-Aug;41(4):49. doi: 10.1051/vetres/2010021. Epub 2010 Apr 13.
This study assessed the effectiveness of a mutant strain of Toxoplasma gondii (RH strain) lacking the mic1 and mic3 genes (Mic1-3KO) against Toxoplasma abortion in sheep. Ewes were inoculated subcutaneously with 10(5) Mic1-3KO tachyzoïtes in three independent experiments. Following vaccination, Mic1-3KO induced a mild febrile response and serum IgG antibodies, which persisted throughout the experiments. Tissue cysts formed in the sheep, but were not, under our experimental conditions, infectious when given orally. Ewes were mated two months after vaccination and were orally challenged with the PRU strain of T. gondii at mid-gestation (400 oocysts in Experiments 1 and 2; 100 oocysts in Experiment 3). Challenge of vaccinated pregnant ewes resulted in a slight febrile response, whereas unvaccinated ewes developed a more severe, characteristic febrile response of longer duration. After challenge, all unvaccinated ewes aborted whereas 62%, 91% and 64% (Experiments 1, 2 and 3 respectively) of the lambs from vaccinated ewes were viable, with no clinical signs of infection. Mic1-3KO was as effective as S48, the strain used as a live vaccine for sheep (Toxovax). A dose of 10(5) Mic1-3KO tachyzoites was sufficient to induce protection (versus a dose of 2x10(6)). Both subcutaneous and intraperitoneal injections were effective. Moreover, preliminary results showed the potential of Mic1-3KO to reduce the development of tissue cysts in lambs born to vaccinated ewes. This study demonstrates that Mic1-3KO is a potent vaccine candidate.
本研究评估了缺失 mic1 和 mic3 基因的刚地弓形虫突变株(RH 株)(Mic1-3KO)对绵羊弓形虫流产的有效性。在三个独立的实验中,将 10(5)个 Mic1-3KO 速殖子皮下接种给母羊。接种后,Mic1-3KO 引起轻度发热反应和血清 IgG 抗体,在整个实验过程中持续存在。组织包囊在绵羊中形成,但在我们的实验条件下,口服时没有传染性。接种两个月后,母羊交配,并在妊娠中期(实验 1 和 2 中为 400 个卵囊;实验 3 中为 100 个卵囊)经口挑战弓形虫 PRU 株。接种的妊娠母羊受到挑战后,出现轻微的发热反应,而未接种的母羊则出现更严重、持续时间更长的特征性发热反应。挑战后,所有未接种的母羊流产,而接种母羊的羔羊中有 62%、91%和 64%(实验 1、2 和 3 分别)存活,没有感染的临床症状。Mic1-3KO 与 S48 一样有效,S48 是用于绵羊的活疫苗(Toxovax)。10(5)个 Mic1-3KO 速殖子足以诱导保护(与 2x10(6)剂量相当)。皮下和腹腔注射均有效。此外,初步结果表明,Mic1-3KO 有潜力减少接种母羊所生羔羊中组织包囊的发展。本研究表明 Mic1-3KO 是一种有效的疫苗候选物。